In parallel with activation of PPAR, EPA and DHA stimulates AMPK activity, an energy-sensing kinase that acts as a potential target for the treatment of obesity [12]. The gene discussed is PPARA; the disease is obesity due to melanocortin 4 receptor deficiency.